15,075 views
During this meeting, Anton Vladimirovich Rodionov spoke about the results of the most important cardiology event of the year — the European Congress of Cardiology 2024. The main positions of the new recommendations on arterial hypertension, atrial fibrillation, and chronic coronary syndromes were considered. Key points: • should mineralocorticoid receptor antagonists be prescribed to patients with heart failure with preserved ejection fraction; • should RAS blockers be discontinued before surgery; should beta-blocker therapy be continued after myocardial infarction if the patient has not developed heart failure; • do we know how to treat cardiac amyloidosis. #ESCCongress #1medtv 00:00 Opening remarks 02:14 New guidelines for arterial hypertension 21:54 New antihypertensive drugs 23:35 New guidelines for atrial fibrillation 31:19 Chronic coronary syndromes - new guidelines 36:44 Peripheral atherosclerosis - new guidelines 49:36 Key studies. Morning and evening administration of antihypertensive drugs 52:31 Discontinuation of RAS blockers before non-cardiac surgery 53:44 Discontinuation of antiplatelet agents before non-cardiac surgery 55:45 Discontinuation of beta-blockers after myocardial infarction 01:01:18 Elective fasting PCI? 01:02:58 Prospects for modern anticoagulants 01:07:03 Finerenone for intermediate and preserved ejection fraction 01:12:13 Treatment of TTR amyloidosis 01:15:30 Answers to questions 01:23:36 End of the broadcast First Medical Channel website: https://1med.tv/ VKontakte: https://vk.com/1medtv Odnoklassniki: https://ok.ru/medtv Telegram: https://t.me/firstmedtv Subscribe to updates and be the first to know about new programs!